Type 2 Diabetes Incidence Up With Higher Intake of Ultraprocessed Food
By Elana Gotkine HealthDay Reporter
FRIDAY, Sept. 27, 2024 -- A higher intake of ultraprocessed food (UPF) is associated with an increased incidence of type 2 diabetes mellitus, according to a study published online Sept. 16 in The Lancet Regional Health.
Samuel J. Dicken, from University College London, and colleagues conducted a prospective cohort analysis of the European Prospective Investigation into Cancer and Nutrition cohort to examine the association between degree of food processing and incident type 2 diabetes. Dietary intake was assessed at baseline and classified as unprocessed/minimally processed food (MPF), processed culinary ingredients (PCI), processed food (PF), and UPF.
The researchers identified 14,236 type 2 diabetes mellitus cases during an average 10.9 years of follow-up of 311,892 individuals. Incident type 2 diabetes was 17 percent higher in association with each 10 percent increment of total daily food intake from UPF. The incidence of type 2 diabetes mellitus was lower in association with each 10 percent increment in MPF + PCI (hazard ratio, 0.94) or PF intake (hazard ratio, 0.92). Lower incident type 2 diabetes mellitus was seen in association with replacing UPF with MPF + PCI or PF. Heterogeneity was seen across subgroups of UPF, with lower incident type 2 diabetes mellitus in association with breads, biscuits and breakfast cereals, sweets and desserts, and plant-based alternatives.
"Higher UPF intake was associated with higher incident type 2 diabetes mellitus, whereas higher intakes of foods with less processing were associated with lower incident type 2 diabetes mellitus," the authors write.
One author disclosed ties to Amazon; a second author disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Semaglutide Plus Intensive Behavioral Therapy Most Beneficial for Weight Loss
FRIDAY, May 23, 2025 -- Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar to that reported in...
In Pediatric Leukemia, Survival Linked to Duration of Overweight, Obesity
TUESDAY, May 20, 2025 -- For children with acute lymphoblastic leukemia (ALL), longer duration of overweight or obesity is associated with lower overall and event-free survival...
GLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, Depression
MONDAY, May 19, 2025 -- For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.